Acumen Pharmaceuticals, Inc. ABOS
0.23 USD -0.01 (-2.21%)
At closeNov 3, 2026, 7:50 PM EST
0.22 -0.01 -4.86%
After hours · Nov 3, 7:50 PM ET
0.225 Day range 0.2481
0.198 52-week range 3.60
- YTD
- -88.89%
- 1 year
- -89.25%
Financial health
Altman Z-Score
-11.68 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 2
Valuation
P/E -1.1×
FY 2019 5y median -2.6× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 1.8×
FY 2019 5y median 1.1× FY 2025
P/FCF -1.1×
FY 2019 5y median -4.3× FY 2025
EV/EBITDA -0.9×
FY 2019 5y median -1.4× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -90.5%
FY 2019 5y median -23.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -172.3%
FY 2019 5y median -44.7% FY 2025
ROIC -121.7%
FY 2019 5y median -24.0% FY 2025
ROA -98.8%
FY 2019 5y median -42.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -8.6%
FY 2019 FY 2025
EPS (diluted) -17.0%
FY 2019 FY 2025
Free Cash Flow -34.1%
FY 2019 FY 2025
Financial Health
Current Ratio 4.1×
FY 2019 5y median 19.0× FY 2025
Quick Ratio 4.1×
FY 2019 5y median 19.0× FY 2025
Debt / Equity 0.4×
FY 2019 5y median 0.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2019 5y median 0.7× FY 2025
Interest Coverage -29.3×
FY 2019 5y median -28.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31